COPD: treatments benefit patients
- PMID: 12583937
- DOI: 10.1016/S0140-6736(03)12467-1
COPD: treatments benefit patients
Comment on
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2. Lancet. 2003. PMID: 12583942 Clinical Trial.
Similar articles
-
[New studies refute steroid opponents. COPD--after all a case for corticosteroids?].MMW Fortschr Med. 2003 Jun 12;145(24):20. MMW Fortschr Med. 2003. PMID: 12866294 German. No abstract available.
-
[Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].Ugeskr Laeger. 2004 Jan 19;166(4):271-4. Ugeskr Laeger. 2004. PMID: 14964108 Clinical Trial. Danish. No abstract available.
-
[Debates surrounding COPD].Rev Mal Respir. 2010 Feb;27(2):106-7. doi: 10.1016/j.rmr.2010.01.013. Rev Mal Respir. 2010. PMID: 20206057 French. No abstract available.
-
[Triple therapy in chronic obstructive pulmonary disease].Arch Bronconeumol. 2010;46 Suppl 8:25-30. doi: 10.1016/S0300-2896(10)70064-8. Arch Bronconeumol. 2010. PMID: 21334553 Review. Spanish.
-
Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. doi: 10.1016/j.ejphar.2005.12.049. Epub 2006 Feb 7. Eur J Pharmacol. 2006. PMID: 16457807 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
